Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203501 · ClinicalTrials.gov registry record
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
A clinical trial of Cerebral Palsy and Infant, Premature, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- 1,339
- Enrollment target
- 15
- Study locations
NCT01203501: Completed study of Cerebral Palsy and Infant, Premature, sponsored by NICHD Neonatal Research Network.
NCT01203501 is a study of Cerebral Palsy and Infant, Premature that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 1,339 participants, above the 215-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (523% higher). The trial reports 15 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01203501, a study of Cerebral Palsy and Infant, Premature, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- 1,339 participants
- Enrollment target
- 15
- Study locations
Study Summary
This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/infant conditions and magnesium exposure (including indications, timing and duration of exposure).
Conditions Studied
Study Locations (15)
Ohio
- Cincinnati Children's Medical Center - Cincinnati
- Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Stanford University - Palo Alto
Connecticut
- Yale University - New Haven
District of Columbia
- George Washington University - Washington D.C.
Florida
- University of Miami - Miami
Georgia
- Emory University - Atlanta
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,339 participants |
| Start Date | 1996-07 |
| Est. Completion | 2000-06 |
What the finished NCT01203501 record still lists
NCT01203501 is an observational study that tracks outcomes without assigning an intervention. Its 1,339 participants enrollment target places it among the larger protocols in the corpus, above the 215-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (523% higher).
The record links to 7 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.
NCT01203501 lists 15 locations in 14 states (Ohio, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT01203501 about?
NCT01203501 is a clinical study titled "In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants". This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/in...
What is the current status of trial NCT01203501?
This trial is currently completed. The enrollment target is 1,339 participants. The study started on 1996-07. Estimated completion is 2000-06.
What conditions does trial NCT01203501 study?
This clinical trial studies the following conditions: Cerebral Palsy, Infant, Premature, Infant, Newborn, Infant, Small for Gestational Age, Infant, Low Birth Weight.
Who is sponsoring clinical trial NCT01203501?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01203501 being conducted?
This trial has 15 study locations across Alabama, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01203501's enrollment target sits among peer trials
1,339 3rd of 91 higher than 89 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06972056 · 1,335 participants · Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia